BCAX
Bicara Therapeutics
BCAX
BCAX
105 hedge funds and large institutions have $475M invested in Bicara Therapeutics in 2025 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 43 increasing their positions, 16 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
4.57% more ownership
Funds ownership: 89.25% → 93.82% (+4.6%)
25% less capital invested
Capital invested by funds: $633M → $475M (-$158M)
54% less call options, than puts
Call options by funds: $11K | Put options by funds: $24K
Holders
105
Holding in Top 10
8
Calls
$11K
Puts
$24K
Top Buyers
| 1 | +$20.7M | |
| 2 | +$18.1M | |
| 3 | +$8.49M | |
| 4 |
BlackRock
New York
|
+$7.15M |
| 5 |
Millennium Management
New York
|
+$6.65M |
Top Sellers
| 1 | -$28.2M | |
| 2 | -$18.2M | |
| 3 | -$18M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$15.4M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$10.9M |
